Financhill
Back

Global X Nasdaq 100 ESG Covered Call ETF Vs. Madrigal Pharmaceuticals Industry Stock Comparison

Sell
39

QYLE
Global X Nasdaq 100 ESG Covered Call ETF

Last Price:
27.70
Seasonality Move:
5.33%
Buy
71

MDGL
Madrigal Pharmaceuticals

Last Price:
320.26
Seasonality Move:
31.67%
Sell
39
Global X Nasdaq 100 ESG Covered Call ETF (QYLE) is a Sell

Is Global X Nasdaq 100 ESG Covered Call ETF a Buy, Sell or Hold?

  • The current Global X Nasdaq 100 ESG Covered Call ETF [QYLE] share price is $27.25. The Score for QYLE is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • QYLE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
71
Madrigal Pharmaceuticals (MDGL) is a Buy

Is Madrigal Pharmaceuticals a Buy, Sell or Hold?

  • The current Madrigal Pharmaceuticals [MDGL] share price is $259.34. The Score for MDGL is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
  • MDGL is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

QYLE Stock Price Chart

What is Global X Nasdaq 100 ESG Covered Call ETF's stock price today?

  • The Global X Nasdaq 100 ESG Covered Call ETF share price today is $27.25
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and QYLE is experiencing slight buying pressure.

MDGL Stock Price Chart

What is Madrigal Pharmaceuticals's stock price today?

  • The Madrigal Pharmaceuticals share price today is $259.34
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MDGL is experiencing buying pressure, which is a positive indicator for future bullish movement.

QYLE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.07 Buy
Relative Strength Index (14 RSI): 45.42 Sell
Chaikin Money Flow: -823 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

MDGL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.45 Buy
Relative Strength Index (14 RSI): 74.74 Buy
Chaikin Money Flow: 898979 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

QYLE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 27.5 Sell
20-day SMA: 27.53 Sell
50-day SMA: 27.22 Buy
200-day SMA: 26.74 Buy
8-day EMA: 27.49 Sell
20-day EMA: 27.47 Sell
50-day EMA: 27.25 Sell
200-day EMA: 26.75 Buy

MDGL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 216.22 Buy
20-day SMA: 214.16 Buy
50-day SMA: 227.04 Buy
200-day SMA: 240.71 Buy
8-day EMA: 223.2 Buy
20-day EMA: 218.42 Buy
50-day EMA: 226.38 Buy
200-day EMA: 233.63 Buy

Global X Nasdaq 100 ESG Covered Call ETF Earnings Growth & QYLE Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Madrigal Pharmaceuticals Earnings Growth & MDGL Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $3.75 per share, a decrease next quarter of $0.00 per share, a decrease this year of $4.12 per share, and an increase next year of $8.67 per share.

Global X Nasdaq 100 ESG Covered Call ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Madrigal Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):